Market Place
Sourcing Support
Sandoz’s Generics Enzalutamide Receives Approval in US
20 Apr 2026 //
FDA
Sandoz’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Sandoz’s Generics Sitagliptin Phosphate Receives Approval in US
14 Jan 2026 //
FDA
Sandoz’s Generics Afatinib Receives Tentative Approval in US
09 Jan 2026 //
FDA
Sandoz’s Receives First Generic Approval for Sitagliptin in US
02 Dec 2025 //
FDA
Sandoz’s Generics Upadacitinib Receives Approval in US
14 Nov 2025 //
FDA
Sandoz’s Generics Carbidopa Receives Tentative Approval In US
12 Nov 2025 //
FDA
Sandoz’s Generics Axitinib Receives Tentative Approval In US
07 Oct 2025 //
FDA
Sandoz’s Biologics Zarxio Receives Suppl Approval in US
21 Aug 2025 //
FDA
Sandoz’s Receives First Generic Approval for Iron Sucrose in US
08 Aug 2025 //
FDA
Sandoz`s Biologics Hyrimoz Receives Suppl Approval in US
29 Jul 2025 //
FDA
Sandoz’s Biologics Omnitrope Receives Suppl Approval in US
09 Jul 2025 //
FDA
Sandoz`s Generics Sugammadex Receives Tentative Approval in US
20 May 2025 //
FDA
Sandoz`s Biologic Enzeevu Receives Suppl Approval in US
10 Feb 2025 //
FDA
Sandoz`s Biologic Jubbonti (Denosumab-bbdz) Receives Suppl Approval in US
24 Oct 2024 //
FDA
Sandoz`s Biologic Wyost (Denosumab-bbdz) Receives Suppl Approval in US
24 Oct 2024 //
FDA
Sandoz`s Biologic Zarxio (Filgrastim) Receives Suppl. Approval in US
22 Oct 2024 //
FDA
Sandoz Inc Biologic Adalimumab-Adaz Receives Supp Approval in US
12 Jun 2024 //
FDA
Sandoz`s Biologic Jubbonti (denosumab-bbdz) Receives Approval in the U.S.
05 Mar 2024 //
FDA
Sandoz` Erelzi (etanercept) Receives Approval in Europe
14 Dec 2023 //
EMA
Sandoz`s Herwenda (trastuzumab) Receives Approval in Europe
23 Nov 2023 //
EMA
Sandoz`s Tyruko (natalizumab) Receives Approval in Europe
20 Nov 2023 //
EMA
Sandoz`s Tyruko (natalizumab) Receives Approval in Europe
17 Oct 2023 //
EMA
Sandoz B2B`s Generic Sugammadex Receives Approval in the U.S.
13 Oct 2023 //
FDA
Sandoz`s Biologic Ziextenzo (pegfilgrastim) Receives Approval in the U.S.
09 Oct 2023 //
FDA
Sandoz`s Biologic Hyrimoz (Adalimumab) Receives Approval in the U.S.
08 Sep 2023 //
FDA
Sandoz`s Biologic Tyruko (natalizumab) Receives Approval in the U.S.
24 Aug 2023 //
FDA
Sandoz`s Generic Encorafenib Receives Approval in the U.S.
17 Jul 2023 //
FDA
Sandoz`s Pregabalin Receives Approval in Europe
13 Jun 2023 //
EMA
Sandoz`s Generic Carbidopa, Levodopa Receives Approval in the U.S.
31 Mar 2023 //
FDA
Sandoz B2B`s Biologic Hyrimoz ( Adalimumab) Receives Approval in the U.S.
20 Mar 2023 //
FDA
Sandoz`s Generic Ibrutinib Receives Approval in the U.S.
10 Feb 2023 //
FDA
Sandoz`s Generic Valbenazine Tosylate Receives Approval in the U.S.
12 Dec 2022 //
FDA
Sandoz`s Generic Fluphenazine Hydrochloride Receives Approval in the U.S.
15 Nov 2022 //
FDA
Sandoz`s Biologic Erelzi (Etanercept) Receives Approval in the U.S.
10 Nov 2022 //
FDA
Sandoz`s Biologic Erelzi (Etanercept) Receives Approval in the U.S.
10 Nov 2022 //
FDA
Sandoz`s Generic Triazolam Receives Approval in the U.S.
08 Nov 2022 //
FDA
Sandoz`s Generic Brexpiprazole Receives Approval in the U.S.
26 Sep 2022 //
FDA
Sandoz B2B`s Generic Bortezomib Receives Approval in the U.S.
26 Jul 2022 //
FDA
Sandoz B2B Generic Neratinib Maleate Receives Approval in the U.S.
05 Jul 2022 //
FDA
Sandoz B2B Generic Pirfenidone Receives Approval in the U.S.
13 Jun 2022 //
FDA
Sandoz`s Generic Bortezomib Receives Approval in the U.S.
14 Mar 2022 //
FDA
Sandoz`s Generic Tafluprost Receives Approval in the U.S.
28 Jan 2022 //
FDA
Sandoz`s Biologic Omnitrope (Somatropin) Receives Approval in the U.S.
25 Jan 2022 //
FDA
Sandoz Inc`s Generic Albuterol Sulfate Receives Approval In US
01 Jun 2021 //
FDA
Sandoz`s Generic Dronedarone Hydrochloride Receives Approval in US
19 May 2021 //
FDA
Sandoz`s Generic Pirfenidone Receives Approval in US
31 Mar 2021 //
FDA
Sandoz`s Generic Ferumoxytol Receives Approval in US
20 Jan 2021 //
FDA
Sandoz`s Generic Cyanocobalamin Receives Approval in US
09 Jan 2021 //
FDA
Sandoz`s Generic Apremilast Receives Approval in U.S
29 Jul 2020 //
FDA
Sandoz`s Erelzi (Etanercept Szzs) Receives Supplemental Approval in US
17 Jun 2020 //
FDA
Sandoz`s Generic Amantadine Receives Approval in U.S
16 Jan 2020 //
FDA
Sandoz`s Ziextenzo (pegfilgrastim-bmez) Receives Supplemental Approval in US
06 Nov 2019 //
FDA
Sandoz`s Zarxio (Filgrastim-Sndz) Receives Supplemental Approval in US
03 Aug 2019 //
FDA
Sandoz Inc.`s Generic Mesalazine Receives Approval in US
12 Jun 2019 //
FDA
